Featured Research

from universities, journals, and other organizations

Malaria On The Increase In The UK

Date:
July 9, 2008
Source:
BMJ-British Medical Journal
Summary:
A huge rise in the numbers of UK residents travelling to malaria endemic areas, combined with a failure to use prevention measures, has significantly increased cases of imported falciparum malaria in the UK over the past 20 years, according to a study published online.

A huge rise in the numbers of UK residents travelling to malaria endemic areas, combined with a failure to use prevention measures, has significantly increased cases of imported falciparum malaria in the UK over the past 20 years, according to a study published on the British Medical Journal website.

Between 1987-91 there were 5120 reported cases of the potentially fatal faliciparum malaria, increasing to 6753 in 2002-6. These findings highlight the urgent need for health messages and services targeted at travellers from migrant groups visiting friends and family abroad, say the authors.

Malaria acquired in one of the 150 countries where it is endemic and then imported into non-endemic countries accounts for a significant proportion of largely preventable disease and death in Europe every year.

Dr Adrian Smith and colleagues from the Health Protection Agency's Malaria Reference Laboratory, present the latest trends in malaria in the UK between 1987 and 2006, using data from the Malaria Reference Laboratory, involving 39 300 confirmed cases of malaria.

64.5% of 20 488 malaria cases amongst UK travellers had visited friends and relatives in malaria endemic countries. This is reflected by the huge increase in the number of UK residents travelling to malaria endemic areas--from 593 000 visits in 1987 to 2.6 million visits in 2004.

Imported malaria cases were heavily concentrated in communities with frequent travel to see friends and relatives in West Africa.

The researchers also note a worrying trend in cases of the potentially fatal falciparum malaria which have increased steady over the past 20 years in the UK. Of all malaria imported to the UK, 96% of falciparum malaria occurred after travel to Africa. Travellers to Nigeria and Ghana, neither common tourist destinations, account for half of all imported falciparum cases.

Importantly, say the authors, only 42% of UK travellers reported taking any form of malaria prophylaxis during their travels. In particular, people visiting friends and relatives in their country of origin were less likely to report using prevention measures than other travellers. For example, amongst malaria cases in travellers to sub-Saharan Africa between1999?, only 7% of people with malaria visiting friends and relatives reported using recommended drugs, compared to 24% of other travellers with malaria.

These findings highlight that health messages are not getting through to ethnic minority groups, particularly those visiting West Africa, warn the authors. "Targeting messages tailored to these groups is essential in primary care and public health...and this would have a substantial impact on UK malaria", they add.

Increasing the use of effective antimalarial prophylactic drugs by travellers visiting sub-Saharan Africa should be a priority, they conclude.

Research into cultural beliefs, knowledge, and attitude towards malaria prevention in people visiting friends and relatives in malaria endemic countries, would help identify how best to target health education campaigns and innovative techniques, says Jane Zuckerman, Director of WHO collaborating centre for reference, research, and training in travel medicine, in an accompanying editorial.


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Smith et al. Imported malaria and high risk groups: observational study using UK surveillance data 1987-2006. BMJ, 2008; 337 (jul03 2): a120 DOI: 10.1136/bmj.a120

Cite This Page:

BMJ-British Medical Journal. "Malaria On The Increase In The UK." ScienceDaily. ScienceDaily, 9 July 2008. <www.sciencedaily.com/releases/2008/07/080703203248.htm>.
BMJ-British Medical Journal. (2008, July 9). Malaria On The Increase In The UK. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/07/080703203248.htm
BMJ-British Medical Journal. "Malaria On The Increase In The UK." ScienceDaily. www.sciencedaily.com/releases/2008/07/080703203248.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins